Vaccines, blood, antisera, toxins and cultures in   Iran

Exports In 2022, Iran exported $40.3M in Vaccines, blood, antisera, toxins and cultures, making it the 54th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 58th most exported product in Iran. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Iran are: Germany ($21.9M), Italy ($11.7M), Kazakhstan ($2.76M), Australia ($1.3M), and Belgium ($828k).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Iran between 2021 and 2022 were Italy ($5.75M), Kazakhstan ($1.58M), and Australia ($1.3M).

Imports In 2022, Iran imported $295M in Vaccines, blood, antisera, toxins and cultures, becoming the 66th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 18th most imported product in Iran. Iran imports Vaccines, blood, antisera, toxins and cultures primarily from: Germany ($120M), Italy ($27.8M), Switzerland ($24.7M), France ($18.6M), and Spain ($13.9M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Iran between 2021 and 2022 were Bulgaria ($8.65M), Spain ($7.66M), and India ($4M).